Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.

HOME
>
論文・技術情報
>
Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.

アブストラクト
ジャーナル名	Diabetes spectrum : a publication of the American Diabetes Association
Pubmed追加日	2015/11/26
投稿者	Jones, S Christopher; Ryan, Debra L; Pratt, Valerie S W; Niak, Ali; Brinker, Allen D
組織名	U.S. Food and Drug Administration Office of Pharmacovigilance and Epidemiology;and Office of New Drugs, Silver Spring, MD.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/26597395/